Saama Technologies and ICON Partner to Unlock the Value of RWE


Applied Clinical Trials

Saama Technologies, a clinical and health data analytics company, and ICON plc, a global provider of drug development and commercialization solutions and services, have partnered to accelerate the use of Real World Evidence across the product lifecycle and drive mission critical decisions for medical affairs, reimbursement, and commercialization functions.

Read the full release here.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.